June 2008 Volume 5 Number 6
Visit Nature Clinical Practice Oncology online to browse the journal.
Now available at http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0UgF0Em
=====================================================================
Are you an American Society for Reproductive Medicine (ASRM) member?
Did you know that you can subscribe to the International Journal for
Impotence Research (IJIR) at the special, discounted rate of $75?
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0znN0Ee
Not an ASRM Member and would like to join? Join ASRM before September 30
and enter the code IJIRDiscount at checkout to receive $50 off your
ASRM Membership. At that time, you may also subscribe to IJIR at the
discounted rate.
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJh0EX
=====================================================================
Attending the ASCO Annual Meeting in Chicago?
Come and see us at Booth 8120 and pick up your complimentary copy of
Nature Clinical Practice Oncology.
We hope to see you there!
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BtZx0E1
=====================================================================
----------------------
EDITORIAL
----------------------
Technology assessment in radiation oncology: time for reassessment?
Jay S Loeffler
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJi0EY
----------------------
RESEARCH HIGHLIGHTS
----------------------
Time to blast clearance predicts outcome in patients with acute myeloid
leukemia
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJj0EZ
Docetaxel versus mitoxantrone in men with hormone-refractory prostate
cancer
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJk0Ea
Cyclophosphamide use in rheumatoid arthritis increases risk of hematologic
malignancies
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJl0Eb
A prognostic scoring system for pancreatic neuroendocrine tumors
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJm0Ec
S-1 plus cisplatin increases overall survival in patients with advanced
gastric cancer
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJn0Ed
PSA velocity does not aid long-term prediction of prostate cancer incidence
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJo0Ee
Immunopanel of five biomarkers provides superior definition of basal-like
breast cancer
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJp0Ef
Recent changes in myeloma therapies have decreased patient mortality
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJq0Eg
One-step method for isolation of circulating tumor cells from whole blood
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJr0Eh
----------------------
PRACTICE POINTS
----------------------
Updated follow-up of patients treated with bortezomib for relapsed
multiple myeloma
Daniele Santini, Bruno Vincenzi and Giuseppe Tonini
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJs0Ei
A comparison of cisplatin and fluorouracil alone or with docetaxel in
squamous cell carcinoma of the head and neck
Kean Ho and Nick Slevin
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJt0Ej
Does prophylactic cranial irradiation reduce the incidence of brain
metastases in extensive small-cell lung cancer?
Lia M Halasz and Noah C Choi
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJu0Ek
Cetuximab for the treatment of patients with colorectal cancer
Jim Cassidy
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJv0El
Comparison of gemcitabine plus platinum analog with gemcitabine alonein
advanced pancreatic cancer
Eileen M O'Reilly and Ghassan K Abou-Alfa
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJw0Em
----------------------
VIEWPOINT
----------------------
What caused the decline in US breast cancer incidence?
Mangesh A Thorat
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJx0En
----------------------
REVIEWS
----------------------
Differences in hematotoxicity between male and female patients with
Hodgkin lymphoma and other malignancies
Beate Klimm and Andreas Engert
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJy0Eo
Therapy Insight: anthracyclines and trastuzumab-the optimal management
of cardiotoxic side effects
Sanjay Popat and Ian E Smith
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJz0Ep
Mechanisms of Disease: cancer stem cells-targeting the evil twin
Andreas Trumpp and Otmar D Wiestler
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJ10Ec
Primer: first do no harm-when is it appropriate to plan a cancer
prevention clinical trial?
Eva Szabo
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJ20Ed
----------------------
CASE STUDY
----------------------
Rapamycin treatment for a child with germline PTEN mutation
Deborah J Marsh, Toby N Trahair, Janet L Martin, Wey Yeeng Chee,
Jan Walker, Edwin P Kirk, Robert C Baxter and Glenn M Marshall
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BwJ30Ee
=====================================================================
Cell Death & Differentiation presents 'Biology of hypoxia-inducible
factors' at http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0BviU0Ei as the
third special issue of 2008.
'Biology of hypoxia-inducible factors' features 10 review articles
focusing on the regulators and biological consequences of HIF
activation. To view the complete table of contents to this special
issue please visit the Special Issues online at
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0Bugw0EF
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/elDd0Xztnp0HjM0Zzu0Ex
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
